Results 191 to 200 of about 655,159 (342)

CLABSI Surveillance in Home Infusion [PDF]

Opeyemi Oladapo-Shittu, Eili Klein, Ilya Shpitser, Jill A. Marsteller, Kimberly S. Weems, Ayşe P. Gürses, Sara E. Cosgrove, Susan M. Hannum, Trung Phung, Sara C. Keller   +9 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

A rapid method to reduce drug interferences for antibody measurements in pegunigalsidase alfa-treated patients with Fabry disease. [PDF]

Front Immunol
Lenders M, Rudolph E, Rudnicki M, Cybulla M, Brand E.   +4 more
europepmc   +1 more source

NITROPRUSSIDE INFUSIONS

British Journal of Anaesthesia, 1983
G G, Graham, D, Rigg
openaire   +2 more sources

Preoperative Infusional Chemoradiation, Selective Intraoperative Radiation, and Resection for Locally Advanced Pelvic Recurrence of Colorectal Adenocarcinoma

, 1996
Andrew M. Lowy, Tyvin A. Rich, John M. Skibber, Ronelle A. DuBrow, Steven A. Curley   +4 more
openalex   +2 more sources

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

Journal of the American Medical Association (JAMA), 2007
J. Tardif, J. Grégoire, P. L’allier, R. Ibrahim, J. Lésperance, T. Heinonen, S. Kouz, C. Berry, R. Basser, M. Lavoie, M. Guertin, J. Rodés‐Cabau   +11 more
semanticscholar   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

A prospective single-arm study on the effects of repeated intravenous infusions of canine adipose-derived mesenchymal stromal cells in dogs with chronic inflammatory enteropathy. [PDF]

Stem Cell Res Ther
Yasumura Y, Teshima T, Michishita M, Suzuki R, Matsumoto H.   +4 more
europepmc   +1 more source

Infusion Thrombophlebitis

International Journal of Clinical Practice, 1970
openaire   +2 more sources

Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid‐refractory, grade III–IV acute graft‐versus‐host disease

British Journal of Haematology, 2013
L. Ball, M. Bernardo, H. Roelofs, M. Tol, B. Contoli, J. Zwaginga, M. Avanzini, A. Conforti, A. Bertaina, G. Giorgiani, C. M. Jol-van der Zijde, M. Zecca, K. Le Blanc, F. Frassoni, R. M. Egeler, W. Fibbe, A. Lankester, F. Locatelli   +17 more
semanticscholar   +1 more source